Cytovation is a biotechnology company dedicated to provide innovative products in life science that improve people’s lives. Our lead compound, CyPep-1, is a novel peptide that selectively targets and destroys tumor cells and bacterias. It has proven efficient in reducing tumor growth across a wide array of different cancer types. It has also shown to be able to eradicate drug resistant bacteria within minutes.

Our Mission

Our focus is on skin tumors and infections with a lead compound in preclinical development for cutaneous warts and multiresistant bacterial infections.